Neonatal Screening for Congenital Hypothyroidism Based on Thyroxine, Thyrotropin, and Thyroxine-Binding Globulin Measurement: Potentials and Pitfalls
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
CONTEXT: The Dutch T(4)-TSH-TBG-based neonatal screening program detects patients with congenital hypothyroidism (CH) of thyroidal (CH-T) as well as central (CH-C) origin. The numbers and characteristics of true-positive and false-positive referrals will differ from other, predominantly TSH-based, screening methods. OBJECTIVE: The present study describes the characteristics of the referred neonates, both CH patients and false positives, and of the reported CH patients with a false-negative screening result born in the study period. DESIGN, SETTING, PATIENTS, AND MAIN OUTCOME MEASURE: For each referred child born between April 1, 2002, and May 31, 2004, screening results and first venous sample results were recorded and classified as transient or permanent CH-T or CH-C or as no CH. RESULTS: In the study period, 430,764 children were screened. Of the 772 children with abnormal screening results, 224 (29%) had CH; another 13 CH patients did not have abnormal screening results, giving an overall CH incidence of 1:1800. Incidences of permanent CH, permanent CH-T, permanent CH-C, and transient CH were 1:2200, 1:2500, 1:21,000, and 1:12,000, respectively. The most frequent explanations for the 548 false-positive referrals (71% of the referred cohort) were severe illness and TBG deficiency (occurring in 198 and 200 children, respectively). CONCLUSIONS: The Dutch incidence figures for CH belong to the highest worldwide, suggesting that the T(4)-TSH-TBG screening program is an efficient method to detect CH of variable etiology and severity. Still, a small percentage of children with CH escaped detection via this screening approach. Severe illness and TBG deficiency appear to be responsible for the majority of false-positive referrals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pitfalls in the newborn screening do exist and can be due to abnormal TH binding globulin, severe concomitant illnesses, as well as several drugs and autoantibodies (24,28).”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reported incidence of central CH detected through neonatal screening lies between 1 in 30,000 and 1 in 16,000, depending on the screening strategy (22–26).”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The incidence of CH partly depends on the screening strategy; based on data from a number of screening programs, the incidence of primary CH lies between 1 in 3000 and 1 in 2000; the highest reported incidence of central CH is ∼1 in 16,000 (1/+++).”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CeH incidence was estimated to range from 1:16,000 to about 1:100,000 in different adult or neonatal populations hypothyroid patients (4, 5, 6, 7, 8).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“the diagnostic strategy used by the Dutch national health system, based on the combined evaluation of total T4 (TT4), thyroxine-binding globulin and TSH (6), has proven to be more sensitive and to uncover milder forms of neonatal CeH that are not detected by the diagnostic strategy used in Japan and USA, based on the combination of low TT4 and normal/low TSH (5, 7).”
From The diagnosis and management of central hypothyroidism in 2018 (2019) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives
Porterfield, S. P. (1993) · Endocrine Reviews · doi:10.1210/er.14.1.94 · Cited by 672
Zoeller, R. T., & Rovet, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01243.x · Cited by 605 · cited 1×
“The critical period for the central nervous system to be dependent on thyroid hormone is known to extend from fetal life until at least the first 2 yr after birth (2, 3).”
BackgroundAction of thyroid hormone in brain
Bernal, J. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344003 · Cited by 358 · cited 1×
“T HORMONE IS important for normal development of the central nervous system (1).”
BackgroundDe Groot, L. J. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2005.10.001 · Cited by 188
Developmental Trends in Cord and Postpartum Serum Thyroid Hormones in Preterm Infants
Williams, F. L. R., Simpson, J., Delahunty, C., Ogston, S. A., Bongers-Schokking, J. J., Murphy, N., van Toor, H., Wu, S.-Y., Visser, T. J., & Hume, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0869 · Cited by 188
Kempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., & Vulsma, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030665 · Cited by 160
Self-citationElmlinger, M. W., Kühnel, W., Lambrecht, H.-G., & Ranke, M. B. (2001) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2001.158 · Cited by 156 · cited 1×
“Because, after an initial peak shortly after birth, plasma FT4 concentration gradually decreases (14), this was considered the reason for the abnormal CH screening result.”
BackgroundNeonatal Detection of Congenital Hypothyroidism of Central Origin
van Tijn, D. A., de Vijlder, J. J. M., Verbeeten, B., Verkerk, P. H., & Vulsma, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2444 · Cited by 139 · cited 1×
“CH-T due to thyroid dysgenesis 78 (78, 0) CH-T due to thyroid dyshormonogenesis 23 (21, 2) CH-T not yet specified 54 (52, 2) CH-T21 15 (15, 0) CH-C 21 (15, 6) CH not yet specified 9 (9, 0) Total 200 (190, 10)”
Self-citationvan Trotsenburg, A. S. P., Vulsma, T., van Rozenburg-Marres, S. L. R., van Baar, A. L., Ridder, J. C. D., Heymans, H. S. A., Tijssen, J. G. P., & de Vijlder, J. J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0130 · Cited by 130
Self-citationHuman Fetal and Cord Serum Thyroid Hormones: Developmental Trends and Interrelationships
Hume, R., Simpson, J., Delahunty, C., van Toor, H., Wu, S. Y., Williams, F. L. R., Visser, T. J., & with collaboration from the Scottish Preterm Thyroid Group (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0573 · Cited by 127
Cited by
Items 101–109 of 109
Cord blood spot thyroid stimulating hormone for screening of congenital hypothyroidism
Narayanan, E., & Seeralar, A. (2020) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20201640
Laboratory Methods in Pediatric Endocrinology
Rapaport, R., GRANT, R., Hyman, S. J., & Stene, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50026-0
van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2022) · doi:10.1093/med/9780198870197.003.0174
Lania, A. G., Giavoli, C., Profka, E., & Beck-Peccoz, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_17
Screening for congenital hypothyroidism with the Dutch T4–TSH–TBG system
(2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0332
Persani, L., & Bonomi, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_9
Persani, L., Casiraghi, A., & Bonomi, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00352-6
Salerno, M., Vigone, M. C., Cassio, A., Cavarzere, P., Cherubini, V., Faienza, M. F., Gastaldi, R., Tuli, G., Wasniewska, M. G., & Olivieri, A. (2026) · Endocrine · doi:10.1007/s12020-026-04656-x
Silvestrin, S. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-14082014-085542 · Cited by 1
Metadata
- Authors
- Kempers, M. J. E., Lanting, C. I., van Heijst, A. F. J., van Trotsenburg, A. S. P., Wiedijk, B. M., de Vijlder, J. J. M., & Vulsma, T.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Netherlands Organisation for Applied Scientific Research (NL)
- Corresponding author
- Kempers, M. J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-09
- Volume
- 91
- Issue
- 9
- Pages
- 3370-3376
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2104577649
- Cited by
- 109
- References
- 23
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 7 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 3 · 2012: 6
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- TNO Repository (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- congenital hypothyroidism, newborn screening, thyroxine, thyroid-stimulating hormone, thyroxine-binding globulin, central hypothyroidism, false positive referrals, screening incidence, transient hypothyroidism
- MeSH terms
- Congenital Hypothyroidism, False Negative Reactions, False Positive Reactions, Humans, Infant, Newborn, Netherlands, Thyroglobulin, Thyrotropin, Thyroxine, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.